Association Between ADAMTS1 Matrix Metalloproteinase Gene Variation, Coronary Heart Disease, and Benefit of Statin Therapy
Arterioscler Thromb Vasc Biol Sabatine et al.
28: 562
Additional Materials
This data supplement includes supporting materials for this study.
Files in this Data Supplement:
- Supplemental Tables -
Table 1--Risk of Fatal Coronary Disease and Non-Fatal Myocardial Infarction and ADAMTS-1 genotype in patients treated with placebo in CARE. Table 2-- Efficacy of Pravastatin in Reducing the Incidence of Fatal Coronary Disease and Non-Fatal Myocardial Infarction in Relation to ADAMTS1 genotype.
- Supplemental Figure -
Mean change in LDL (mg/dl) from baseline to last measurement (at5 years in 93% of patients), stratified by treatment arm and genotype.
